Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Biocartis Group NV
  6. Summary
    BCART   BE0974281132

BIOCARTIS GROUP NV

(BCART)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Bruxelles
07/28/2021 07/29/2021 07/30/2021 08/02/2021 08/03/2021 Date
4(c) 4.015(c) 4.01(c) 3.98(c) 4 Last
17 814 6 931 25 020 192 871 33 339 Volume
-0.37% +0.37% -0.12% -0.75% +0.50% Change
More quotes
Estimated financial data (e)
Sales 2021 56,0 M 66,5 M 66,5 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 79,9 M 94,9 M 94,9 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 229 M 272 M 272 M
Capi. / Sales 2021 4,09x
Capi. / Sales 2022 2,87x
Nbr of Employees 484
Free-Float 83,5%
More Financials
Company
Biocartis Group NV is a Belgium-based company, which specializes in the development of molecular diagnostic systems, especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The group has the Idylla system to deliver results within a period of between 35 to 150... 
More about the company
All news about BIOCARTIS GROUP NV
08/02BIOCARTIS : Manufacturing Capacity Impaired Following Belgian Warehouse Fire
MT
08/02BIOCARTIS : Update on Fire Incident at Biocartis Warehouse
PU
08/02PRESS NEWS BIOCARTIS GROUP NV : Update on Fire Incident at Biocartis Warehouse
AQ
07/31BIOCARTIS : Fire Incident at Biocartis Warehouse in Mechelen, Belgium
PU
07/31PRESS NEWS BIOCARTIS GROUP NV : Fire Incident at Biocartis Warehouse in Mechelen..
AQ
07/31Biocartis Group NV Reports Fire Incident at Biocartis Warehouse in Mechelen, ..
CI
06/22GeneproDX announced that it has received $3.2 million in funding from Biocart..
CI
06/04BIOCARTIS : Results of the Extraordinary Shareholders' Meeting held on 4 June 20..
PU
06/04PRESS RELEASE BIOCARTIS GROUP NV : Results of the Extraordinary Shareholders' Me..
AQ
06/04BIOCARTIS GROUP NV : Proxy Statments
CO
05/17PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Extraordinary Shareholders'..
AQ
05/17BIOCARTIS GROUP NV : Extraordinary general shareholder meeting
CO
05/14BIOCARTIS : Results of the Shareholders' Meetings held on 14 May 2021
PU
05/14PRESS RELEASE BIOCARTIS GROUP NV : Results of the Shareholders' Meetings held on..
AQ
05/14BIOCARTIS GROUP NV : Proxy Statments
CO
More news
News in other languages on BIOCARTIS GROUP NV
08/02BRUSSELS STOCK EXCHANGE : Bel20 sluit in het groen
08/02Brussel in het groen
08/02Brussel in de lift
08/02Brussel opent hoger
08/02BRUSSELS STOCK EXCHANGE : Bel20 start handelsweek in het groen
More news
Chart BIOCARTIS GROUP NV
Duration : Period :
Biocartis Group NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOCARTIS GROUP NV
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 3,98 €
Average target price 7,75 €
Spread / Average Target 94,7%
Managers and Directors
Herman Verrelst Chief Executive Officer & Executive Director
Jean-Marc Roelandt Chief Financial Officer
Christian Reinaudo Independent Chairman
Benoit Devogelaere Chief Technology Officer
Piet Houwen Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIOCARTIS GROUP NV-14.41%272
NOVOCURE LIMITED-12.92%15 582
MASIMO CORPORATION2.13%15 091
GETINGE AB97.03%12 021
PENUMBRA, INC.51.59%9 678
ASAHI INTECC CO., LTD.-19.39%7 524